CSIRO’s Biomedical Materials Translational Facility (BMTF) helps MedTech companies develop their discoveries into biomedical products. The facility holds ISO 9001:2015 certification for the development and manufacturing of materials and devices suitable for preclinical investigation and Phase I clinical trials in Australia. With an ISO 7 cleanroom, the BMTF is equipped for performing wet chemistry, materials synthesis, processing, device fabrication, and surface modification.